Neurology

Results from the OCEANIC-STROKE trial show that the investigational Factor XIa inhibitor, asundexian, not only reduces the recurrent ischaemic stroke risk, but when they do occur, they are less likely to be disabling or fatal.

Neurologists Kathrin LaFaver and Indu Subramanian discuss a simple approach to spiritual assessment of patients, differences between spirituality and religion, and bringing more meaning to your practice.

Dr Kenny Lin reviews the updated ACC/AHA dyslipidemia guidelines and explains why primary care clinicians shouldn't blindly accept the new rules as gospel.

How well do you know about the management of Duchenne muscular dystrophy? Test your knowledge with this quick quiz.

US cardiologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.